News Information
The chairman of Zhuhai Meditech Biopharmaceutical Co., Ltd. visited Dalian Xinyi Agricultural Co., Ltd.
Release time:
2020-05-19
On July 9, 2019, Chairman Wu of Zhuhai Midiatech Biopharmaceutical Co., Ltd. visited Dalian Xinyi Agricultural Co., Ltd. (hereinafter referred to as "Midiatech") for a tour and exchange. Both parties had friendly discussions on cooperation in areas such as the cultivation of American Taxus media and the extraction technology of paclitaxel.
Chairman Li Yan of Xinyi Agriculture (first from the left) warmly received Chairman Wu of Midiatech.
Midiatech Biopharmaceutical Leader
Midiatech is a key investment attraction project in Zhuhai City, located in the Zhuhai Bio-Industry Park, covering an area of 50 acres, with a phase one construction area of 13,000 square meters. It has a new anti-liver cancer drug - Sanjie Pian, which has obtained a national invention patent (ZL200410050749.3), with the national drug approval number Z20040106, and is exclusive patented. It can effectively treat liver cancer and also prevent the transformation of liver cirrhosis and ascites into liver cancer. Additionally, there are new drugs for treating lung cancer, nasopharyngeal cancer, and laryngeal cancer, such as Baishan Pian; for treating gastric cancer, intestinal cancer, and pancreatic cancer, there is Xiaojie Ling; and for treating breast cancer and uterine cancer, there is Rukangning. All these anti-cancer new drugs have obtained national invention patents.
Our general manager and company representatives warmly received Chairman Wu as the host. We were honored to introduce the company profile and development history to Chairman Wu at the Xinyi Taxus media cultivation base and visited some projects and landscapes of the base.
Chairman Li Yan of Xinyi Agriculture and Chairman Wu of Midiatech visited the base.
Chairman Li introduced and explained the American Taxus media to Chairman Wu.
Chairman Li and representatives of our company took a photo with Chairman Wu of Midiatech.
Dalian Xinyi Agricultural Co., Ltd. is a key incubation enterprise and leading demonstration enterprise in the Dalian National Agricultural Science and Technology Park, covering an area of 120,000 square meters, with more than 70 varieties of premium Phalaenopsis orchids and over 300,000 American Taxus media. The Xinyi Agricultural base is also the largest American Taxus media cultivation base in the country, providing raw materials for the anti-cancer drug paclitaxel to major pharmaceutical manufacturers.
"National Treasure" American Taxus media
Taxus media is a rare and endangered species left over from the Quaternary glacial period 2.5 million years ago, known as a living fossil among plants. It has medicinal value and air purification effects, and is referred to as a "national treasure" by 42 countries where Taxus media grows.
Paclitaxel, also known as Taxol, is currently the most outstanding natural anti-cancer drug discovered, widely used in clinical treatment of breast cancer, ovarian cancer, and some head and neck cancers and lung cancers.
The scarcity of natural resources of paclitaxel has attracted great attention from botanists, chemists, pharmacologists, and molecular biologists, making it a focus of research and a star in anti-cancer studies in the second half of the 20th century.
In the afternoon, the leadership team of Xinyi invited Chairman Wu to our floral art store, Xinyi Huadu, located on the second floor of Central Avenue, for tea, flower appreciation, and discussions about the development history and local customs of both companies. The scene was beautiful beyond description.
This visit not only allowed Xinyi to feel the culture of the Midiatech Group but also let the Midiatech Group understand the excellence of our Taxus media and the beauty of Phalaenopsis orchids.
In the future development path, Xinyi hopes to work hand in hand with the Midiatech Group, creating more cooperation opportunities and looking forward to a bright tomorrow together!
Next Page
Related Information
Traditional Chinese Medicine for Liver Cancer and Liver Cirrhosis - Sanjie Pian, safeguarding 447 million chronic liver disease patients.
2022Year4Month15to21The day is the28first National Cancer Prevention and Control Publicity Week
In 2021, the anti-liver cancer traditional Chinese medicine - Sanjie Pian passed the expert review by the Ministry of Science and Technology, achieving a level of technological advancement that is considered leading in the country. The research and development results have been included in the National Science and Technology Achievements Database (No. 6012021Y0389). It was publicly announced on the National Science and Technology Achievements Registration Work Platform (Guokewang) in March 2022.
WeChat Subscription
Website mobile
Links:
Zhuhai Municipal Government
Guangdong Provincial Drug Administration
National Medical Products Administration
Address: Office Building Service Hotline, 150 Gate Road, Sanzao Town, Jinwan District, Zhuhai City:+86756-6331366